Published online 23 April 2004
Nucleic Acids Research, 2004, Vol. 32, No. 7 2202-2213
© 2004 Oxford University Press
Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene
Department of Microbiology, College of Natural Sciences, Pusan National University, Busan 609-735, Korea
*To whom correspondence should be addressed. Tel: +82 51 510 2178; Fax: +82 51 514 1778; Email: kljang{at}pusan.ac.kr
Received March 1, 2004; Revised and Accepted March 30, 2004
Despite the extensive studies on the roles of hepatitis B virus X protein (HBx), the effects of HBx on the important cellular processes such as cell growth, cell transformation and apoptosis remain controversial. Our previous study showed that the balance between p53-dependent activation and p53-independent repression by HBx determines the expression level of cyclin-dependent kinase inhibitor p21. In the present study, we further demonstrate that HBx natural variants have differential effects on p21 expression. The critical sites in HBx were identified as residues Ser-101 for activation and Met-130 for repression, respectively. The HBx variants with Ser-101 instead of Pro-101 stabilized p53 more efficiently, probably by protecting it from the MDM2-mediated degradation. On the other hand, the Met-130-containing HBx strongly repressed p21 expression by inhibiting Sp1 activity. Overall, the effect of HBx on p21 expression seems to be determined by the balance between the opposite activities. Depending on their potentials to regulate p21 expression, HBx variants showed different effects on the cell cycle progression, and eventually on the cell growth rate, implicating its biological significance. The present study may provide a clue to explaining the contradictory results related to cell growth regulation by HBx as well as to understanding the progression of hepatic diseases in HBV-positive patients.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. K. Jung, H. J. Kwun, J.-O. Lee, P. Arora, and K. L. Jang Hepatitis B virus X protein differentially affects the ubiquitin-mediated proteasomal degradation of beta-catenin depending on the status of cellular p53 J. Gen. Virol., August 1, 2007; 88(8): 2144 - 2154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Jung, P. Arora, J. S. Pagano, and K. L. Jang Expression of DNA Methyltransferase 1 Is Activated by Hepatitis B Virus X Protein via a Regulatory Circuit Involving the p16INK4a-Cyclin D1-CDK 4/6-pRb-E2F1 Pathway Cancer Res., June 15, 2007; 67(12): 5771 - 5778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N H Park, I H Song, and Y-H Chung Chronic hepatitis B in hepatocarcinogenesis. Postgrad. Med. J., August 1, 2006; 82(970): 507 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. C. Lee, J. Ren, E.-T. Wong, K. H. K. Ban, L. A. Lee, and C. G. L. Lee The Hepatitis B Virus X Protein Sensitizes HepG2 Cells to UV Light-induced DNA Damage J. Biol. Chem., September 30, 2005; 280(39): 33525 - 33535. [Abstract] [Full Text] [PDF]
|
|